Profil
Karen Lowe is currently the Director-Finance & Director at Oxford Cannabinoid Technologies Ltd. and a Member at the Association of Certified Fraud Examiners.
She previously worked as a Non-Executive Director at Oxford Cannabinoid Technologies Holdings Plc in 2022.
Ms. Lowe completed her undergraduate degree at Leeds Beckett University and Bremen University of Applied Sciences.
Postes actifs de Karen Lowe
| Sociétés | Poste | Début |
|---|---|---|
Association of Certified Fraud Examiners
Association of Certified Fraud Examiners Miscellaneous Commercial ServicesCommercial Services Provides anti-fraud training and educational services | Corporate Officer/Principal | - |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Engages in researching, developing and licensing cannabinoid-based compounds and therapies | Directeur Financier/CFO | - |
Anciens postes connus de Karen Lowe
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | Directeur Financier/CFO | 26/08/2022 |
Formation de Karen Lowe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Leeds Beckett University
Leeds Beckett University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Certified Fraud Examiners
Association of Certified Fraud Examiners Miscellaneous Commercial ServicesCommercial Services Provides anti-fraud training and educational services | Commercial Services |
Bremen University of Applied Sciences
Bremen University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Cannabinoid Technologies Ltd.
Oxford Cannabinoid Technologies Ltd. Pharmaceuticals: OtherHealth Technology Engages in researching, developing and licensing cannabinoid-based compounds and therapies | Health Technology |
Oxford Cannabinoid Technologies Holdings Plc
Oxford Cannabinoid Technologies Holdings Plc Pharmaceuticals: MajorHealth Technology Provides cannabinoid drug development services | Health Technology |
















